GO
Loading...

Enter multiple symbols separated by commas

Stocks Baxter International Inc

More

  • LONDON, Aug 13- Baxalta wants Shire to improve on its $30 billion bid significantly before it will engage in talks, while its Dublin- based rival could sweeten its offer if it gets to see the U.S. biotech company's books, according to sources on both sides. Bolstered by the backing of its shareholders, Baxalta's management is digging in by scorning Shire's initial...

  • *Baxalta CEO says can get to Shire bid value on its own. LONDON, Aug 10- Shire Chief Executive Flemming Ornskov is stepping up his campaign to get Baxalta to the negotiating table as he pushes the benefits a $30 billion takeover offer to the U.S. biotech company's shareholders. Shares in Shire and Baxalta both rose on Monday, helped by a bullish note from Cowen analyst...

  • Shire CEO steps up drive to get Baxalta board talking Monday, 10 Aug 2015 | 11:20 AM ET

    LONDON, Aug 10- Shire Chief Executive Flemming Ornskov is stepping up his campaign to get Baxalta to the negotiating table as he pushes the benefits a $30 billion takeover offer to the U.S. biotech company's shareholders. He has a fight on his hands, with investors in newly listed Baxalta arguing he must pay more, although one person close to the Dublin- based...

  • BOSTON, Aug 5- Billionaire investor Daniel Loeb on Wednesday asked for two board seats at Baxter International after publicly unveiling the roughly $2 billion stake his hedge fund, Third Point, recently took in the healthcare company. Loeb wrote a letter to Baxter Chief Executive Robert Parkinson, telling him that Third Point is now the company's biggest...

  • BOSTON, Aug 5- Billionaire investor Daniel Loeb on Wednesday asked for two board seats at Baxter International after publicly unveiling the roughly $2 billion stake his hedge fund, Third Point, recently took in the healthcare company. Loeb wrote a letter to Baxter Chief Executive Robert Parkinson, telling him that Third Point is now the company's biggest...

  • *Baxalta says offer "significantly undervalues" group. LONDON, Aug 5- Shire Chief Executive Flemming Ornskov will need to dig deeper in his pocket if he wants to win U.S. biotech company Baxalta. The Danish doctor running the London- listed drugmaker from offices in Massachusetts is not taking the easy option with his $30 billion run at Baxalta.

  • Cramer: Most lucrative way to unlock stock value Tuesday, 4 Aug 2015 | 6:56 PM ET
    Baxter International Inc.

    Jim Cramer reminds investors that breaking up is not always hard to do. It's easy to unlock value!

  • LONDON, Aug 4- Drugmaker Shire said on Tuesday it was seeking to buy Baxalta, a company spun-off by Baxter International last month, for $30 billion to forge the leading global specialist in rare diseases. Shire said its unsolicited offer of 0.1687 Shire American depositary receipts per share valued each Baxalta share at $45.23. Shares in Baxalta jumped 19...

  • After-hours buzz: Family Dollar, Xoom & more Wednesday, 1 Jul 2015 | 5:50 PM ET
    Traders work on the floor of the New York Stock Exchange.

    Check out the companies making headlines after the bell Wednesday: Family Dollar, Energizer & more.

  • Halfway through the Halftime Portfolio challenge Wednesday, 1 Jul 2015 | 4:28 PM ET
    Halftime Portfolio: Comeback plan

    Halfway through the Halftime Portfolio competition. All but two competitors are outperforming the S&P 500 so far.

  • June 26- Drug developer Celladon Corp said on Friday it may liquidate itself if it were unable to find a buyer, and was suspending development of its gene therapy for heart failure. Celladon said if it were to liquidate during the third quarter ending September, the net cash available for distribution to shareholders would be about $25 million- $30 million.

  • Early movers: CI, WMB, PFE, ALL, AAPL & more Monday, 22 Jun 2015 | 7:47 AM ET
    Traders work on the floor of the New York Stock Exchange (NYSE).

    Some of the names on the move ahead of the open.

  • Autos & pharma stocks top trades to go Wednesday, 10 Jun 2015 | 1:50 PM ET

    The "Halftime Report" traders give their top trades before the closing bell.

  • After BMY's drop, cancer drug stocks set to move? Monday, 1 Jun 2015 | 5:00 AM ET
    Attendees walk through the lobby at the American Society of Clinical Oncology (ASCO) annual meeting in Chicago. (File Photo).

    The stock-moving news flow started early out of the American Society of Clinical Oncology meeting in Chicago.

  • Here's why Puma, Clovis shares are poised to move Friday, 29 May 2015 | 2:49 PM ET
    Attendees walk through the lobby at the American Society of Clinical Oncology (ASCO) annual meeting in Chicago. (File Photo).

    It's that time again. With researchers set to convene at the American Society of Clinical Oncology meeting, here are the stocks to watch.

  • Biotech's boom fuels real estate here Thursday, 30 Apr 2015 | 12:11 PM ET
    Signage sits on display in an atrium at Genzyme Corp.'s headquarters in Cambridge, Massachusetts.

    As biotech has boomed over the last few years, so has real estate in Kendall Square in Cambridge, Massachusetts.

  • Charts say market headed lower. What to sell Monday, 6 Apr 2015 | 11:02 AM ET
    NYSE New York Stock Exchange traders markets

    Technical analysts, those who study charts to make buying and selling decisions, believe a bigger pullback could begin this week.

  • Pete Najarian buys Apple ahead of Watch release Tuesday, 31 Mar 2015 | 12:52 PM ET
    Tim Cook introduces the Apple Watch

    Pete Najarian bought shares of Apple for his Halftime Report Portfolio on the belief that the Apple Watch and new iPhones this year will drive the shares higher.

  • LONDON, March 12- Pfizer is seeking new vaccine opportunities across the age spectrum as it broadens its portfolio by delivering shots into the arms of adolescents and the elderly, as well as infants. For many years the vaccines industry has been dominated by five big companies, but that has shrunk to four with GlaxoSmithKline's purchase of Novartis' business.

  • Lightning Round: This stock needs to split up Tuesday, 10 Feb 2015 | 7:31 PM ET
    Mad Money Lightning Round

    Are you ready skeedaddy???!!! It's time for the Lightning Round. Cramer makes the call on viewer favorites.